Dynamic monitoring of the efficacy of T-cell immunotherapy

Chimeric antigen receptor T-cell (CAR-T) immunotherapy has become a hot research topic both domestically and internationally due to its significant therapeutic effects in treating hematological malignancies. Accurately assessing, monitoring, and managing CAR-T therapy in the complex clinical environment of CAR-T treatment presents a major challenge. Immune profiling sequencing technology can digitally evaluate and monitor the treatment process and outcomes by tracking the dynamic changes of three types of cells: tumor cells (for efficacy assessment through MRD monitoring), CAR-T cells (for monitoring CAR-T expansion and persistence), and newly generated autologous immune cells (for immune reconstitution).

Contact Us

8/F, Block A, Hengtemei Building, No. 3 Ganli Road, Longgang District, Shenzhen; 402, Kelente R&D Building, Ganli Road, Longgang District, Shenzhen.

TEL: 0755-8453-4802

EMAIL

query@neoimmune.cn